Yongxiang Zheng

Title: Yongxiang Zheng: Innovator in Gene Therapy

Introduction

Yongxiang Zheng is a prominent inventor based in Beijing, China. He has made significant contributions to the field of gene therapy, particularly through his innovative work with adeno-associated viruses.

Latest Patents

Zheng holds a patent for an "Adeno-associated virus with site-directed mutagenesis and site-directed modification and preparation method and application thereof." This invention relates to an adeno-associated virus that utilizes genetic code expansion techniques to incorporate non-natural amino acids into the virus capsid protein VP1. The resulting virus maintains production, transduction, and mobility comparable to wild-type viruses. This advancement allows for the coupling of the virus with functional molecules, making it a valuable tool for genetic therapy and other applications.

Career Highlights

Zheng is affiliated with Peking University, where he continues to advance research in the field of virology and gene therapy. His work has garnered attention for its potential applications in targeting genetic therapies and understanding virus binding proteins.

Collaborations

Zheng has collaborated with notable colleagues, including Demin Zhou and Chuanling Zhang, contributing to the advancement of research in their respective fields.

Conclusion

Yongxiang Zheng's innovative work in the development of adeno-associated viruses represents a significant step forward in gene therapy. His contributions continue to influence the landscape of genetic research and therapeutic applications.